Related Experiment Video
Updated: Jul 30, 2025

Robotic Myotomy and Partial Fundoplication for Achalasia
Published on: August 11, 2023
EndoFLIP assessment of pyloric sphincter in children: a single-center experience
Mara Popescu1, Emily White2, Mohamed Mutalib1,2
1Faculty of Life Sciences and Medicine, Kings College London, London, UK.
Insights
Children with neurodisabilities and foregut symptoms often have poor pyloric distensibility. Intrapyloric Botulinum Toxin improved symptoms and pyloric measurements in this study.
Area of Science:
- Pediatric Gastroenterology
- Neurodisability Research
- Medical Device Technology
Background:
- Gastrointestinal issues like vomiting and poor feeding are prevalent in children with neurodisabilities.
- The Endolumenal functional lumen imaging probe (EndoFLIP) assesses pyloric compliance and distensibility, predicting treatment response in adults with gastroparesis.
- This study focuses on pyloric measurements using EndoFLIP in pediatric patients with neuromuscular disabilities and foregut symptoms.
Purpose of the Study:
- To review pyloric muscle measurements obtained via EndoFLIP in children with neuromuscular disabilities.
- To evaluate the clinical effectiveness of intrapyloric Botulinum Toxin in this patient group.
- To correlate EndoFLIP measurements with clinical outcomes.
Main Methods:
- A retrospective review of clinical notes from March 2019 to January 2022 at Evelina London Children's Hospital.
- EndoFLIP catheter insertion via an existing gastrostomy tract during endoscopy.
- Pyloric measurements (diameter, compliance, distensibility) were taken pre- and post-Botulinum Toxin injection at various balloon volumes.
Main Results:
- 335 measurements from 12 children (mean age 10.7 years) were analyzed.
- Significant improvements in diameter, compliance, and distensibility were observed post-Botulinum Toxin injection.
- Eleven out of twelve children reported clinical symptom improvement.
Conclusions:
- Children with neurodisabilities and foregut symptoms exhibit reduced pyloric distensibility and compliance.
- EndoFLIP assessment via a gastrostomy tract is a feasible and rapid procedure.
- Intrapyloric Botulinum Toxin demonstrated safety and efficacy, improving both clinical symptoms and objective measurements in this pediatric cohort.
Background:
Gastrointestinal complaints are common in children with neurodisabilities, vomiting, retching and poor feed tolerance are frequently reported. Endolumenal functional lumen imaging probe (EndoFLIP) is used to assess compliance and distensibility of the pylorus and can predict response to Botulinum Toxin in adult with gastroparesis. We aimed to review pyloric muscle measurements using EndoFLIP in children with neuromuscular disabilities and significant foregut symptoms and to assess the clinical response to intrapyloric Botulinum Toxin.
Methods:
Retrospective review of clinical notes of all children who underwent pyloric EndoFLIP assessment in Evelina London Children's Hospital from March 2019 to January 2022. EndoFLIP catheter was inserted at the time of endoscopy via existing gastrostomy tract.
Results:
A total of 335 measurement from 12 children were obtained, mean age 10.7±4.2 years. Measurements (pre and post Botox) were obtained with 20, 30 and 40 mL balloon volume. Diameter (6.5, 6.6), (7.8, 9.4) and (10.1, 11.2), compliance (92.3, 147.9), (89.7, 142.9) and (77, 85.4) mm3/mmHg, distensibility (2.6, 3.8), (2.7, 4.4) and (2.1, 3) mm2/mmHg and balloon pressure was (13.6, 9.6), (20.9, 16.2) and (42.3, 35) mmHg. Eleven children reported clinical symptom improvement after Botulinum Toxin injection. Balloon pressure was positively correlated to diameter (r=0.63, P<0.001).
Conclusions:
Children with neurodisabilities who present with symptoms suggestive of poor gastric emptying do have a low pyloric distensibility and poor compliance. EndoFLIP via existing gastrostomy tract is quick and easy to perform. Intrapyloric Botulinum Toxin appears to be safe and effective in this cohort of children leading to clinical and measurements improvement.
More Related Videos
Related Concept Videos
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Esophageal Strictures-I: Introduction
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Endoscopic Procedures I: Esophagogastroduodenoscopy
During an EGD, the endoscope can be used to:
Endoscopic Procedures V: ERCP
Patient...
Gastric Emptying

